{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-21-012392","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2021-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.672112+00:00","generated_at":"2026-06-28T07:01:44.625337+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Zomedica discloses 10b5-1 trading plans covering up to 8.06M common shares","bullets":["Three directors, one executive officer, and other employees adopted Rule 10b5-1 plans for the period Jan 1–Dec 31, 2022.","Plans cover a maximum of 8,061,842 common shares, including 7,101,842 shares from outstanding stock options.","Plans were adopted for long-term financial planning, retirement, and diversification; trades are pre-arranged but not guaranteed."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-21-012392","json":"https://secwatch.observer/filing/0001654954-21-012392.json","markdown":"https://secwatch.observer/filing/0001654954-21-012392.md","text":"https://secwatch.observer/filing/0001654954-21-012392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000165495421012392/0001654954-21-012392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000165495421012392/zom_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T07:01:44.625337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}